Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Novel Generation of Tailored Antimicrobial Drugs Based on Recombinant Multidomain Proteins.
López-Cano A, Ferrer-Miralles N, Sánchez J, Carratalá JV, Rodriguez XR, Ratera I, Guasch J, Pich OQ, Bierge P, Garcia-de-la-Maria C, Miro JM, Garcia-Fruitós E, Arís A; FUNCATH Investigators. López-Cano A, et al. Among authors: garcia de la maria c. Pharmaceutics. 2023 Mar 26;15(4):1068. doi: 10.3390/pharmaceutics15041068. Pharmaceutics. 2023. PMID: 37111554 Free PMC article.
High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis.
Miró JM, Entenza JM, Del Río A, Velasco M, Castañeda X, Garcia de la Mària C, Giddey M, Armero Y, Pericàs JM, Cervera C, Mestres CA, Almela M, Falces C, Marco F, Moreillon P, Moreno A; Hospital Clinic Experimental Endocarditis Study Group. Miró JM, et al. Antimicrob Agents Chemother. 2012 Aug;56(8):4511-5. doi: 10.1128/AAC.06449-11. Epub 2012 May 29. Antimicrob Agents Chemother. 2012. PMID: 22644033 Free PMC article.
Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.
García-de-la-Mària C, Pericas JM, Del Río A, Castañeda X, Vila-Farrés X, Armero Y, Espinal PA, Cervera C, Soy D, Falces C, Ninot S, Almela M, Mestres CA, Gatell JM, Vila J, Moreno A, Marco F, Miró JM; Hospital Clinic Experimental Endocarditis Study Group. García-de-la-Mària C, et al. Antimicrob Agents Chemother. 2013 May;57(5):2319-25. doi: 10.1128/AAC.01921-12. Epub 2013 Mar 11. Antimicrob Agents Chemother. 2013. PMID: 23478959 Free PMC article.
Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial.
del Río A, Gasch O, Moreno A, Peña C, Cuquet J, Soy D, Mestres CA, Suárez C, Pare JC, Tubau F, Garcia de la Mària C, Marco F, Carratalà J, Gatell JM, Gudiol F, Miró JM; FOSIMI Investigators. del Río A, et al. Clin Infect Dis. 2014 Oct 15;59(8):1105-12. doi: 10.1093/cid/ciu580. Epub 2014 Jul 21. Clin Infect Dis. 2014. PMID: 25048851 Clinical Trial.
Reply to Kaasch et al.
Cervera C, Garcia de la Maria C, Pericas JM, Moreno A, Miro JM. Cervera C, et al. Clin Infect Dis. 2015 Feb 15;60(4):669-70. doi: 10.1093/cid/ciu875. Epub 2014 Nov 3. Clin Infect Dis. 2015. PMID: 25371491 No abstract available.
Epidemiology and prognosis of coagulase-negative staphylococcal endocarditis: impact of vancomycin minimum inhibitory concentration.
García de la Mària C, Cervera C, Pericàs JM, Castañeda X, Armero Y, Soy D, Almela M, Ninot S, Falces C, Mestres CA, Gatell JM, Moreno A, Marco F, Miró JM; Hospital Clinic Endocarditis Study Group. García de la Mària C, et al. PLoS One. 2015 May 11;10(5):e0125818. doi: 10.1371/journal.pone.0125818. eCollection 2015. PLoS One. 2015. PMID: 25961578 Free PMC article.
Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.
del Río A, García-de-la-Mària C, Entenza JM, Gasch O, Armero Y, Soy D, Mestres CA, Pericás JM, Falces C, Ninot S, Almela M, Cervera C, Gatell JM, Moreno A, Moreillon P, Marco F, Miró JM; Hospital Clinic Experimental Endocarditis Study Group. del Río A, et al. Antimicrob Agents Chemother. 2015 Nov 2;60(1):478-86. doi: 10.1128/AAC.02139-15. Print 2016 Jan. Antimicrob Agents Chemother. 2015. PMID: 26525803 Free PMC article.
Safety and efficacy of daptomycin in outpatient parenteral antimicrobial therapy: a prospective and multicenter cohort study (DAPTODOM trial).
Cervera C, Sanroma P, González-Ramallo V, García de la María C, Sanclemente G, Sopena N, Pajarón M, Segado A, Mirón M, Antón F, Basterretxea A, Cuende A, Miró JM; DAPTODOM Investigators. Cervera C, et al. Infect Dis (Lond). 2017 Mar;49(3):200-207. doi: 10.1080/23744235.2016.1247292. Epub 2016 Nov 8. Infect Dis (Lond). 2017. PMID: 27820968
Perturbations of Phosphatidate Cytidylyltransferase (CdsA) Mediate Daptomycin Resistance in Streptococcus mitis/oralis by a Novel Mechanism.
Mishra NN, Tran TT, Seepersaud R, Garcia-de-la-Maria C, Faull K, Yoon A, Proctor R, Miro JM, Rybak MJ, Bayer AS, Arias CA, Sullam PM. Mishra NN, et al. Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02435-16. doi: 10.1128/AAC.02435-16. Print 2017 Apr. Antimicrob Agents Chemother. 2017. PMID: 28115347 Free PMC article.
AUC/MIC Pharmacodynamic Target Is Not a Good Predictor of Vancomycin Efficacy in Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis.
Castañeda X, García-de-la-Mària C, Gasch O, Pericas JM, Armero Y, Soy D, García-González J, Falces C, Ninot S, Almela M, Ambrosioni J, Quintana E, Vidal B, Fuster D, Llopis J, Soto S, Moreno A, Marco F, Miró JM; Hospital Clinic Endocarditis Study Group. Castañeda X, et al. Antimicrob Agents Chemother. 2017 May 24;61(6):e02486-16. doi: 10.1128/AAC.02486-16. Print 2017 Jun. Antimicrob Agents Chemother. 2017. PMID: 28373187 Free PMC article.
83 results